POLL: Have You Treated Generalized Pustular Psoriasis in Your Practice?

Poll

Click here to answer this week's poll.

Have You Treated Generalized Pustular Psoriasis in Your Practice?

Yes
No
Related Videos
Related Content

LEO Pharma to Acquire Timber Pharmaceuticals

August 21st 2023

Abeona Files Briefing Package For EB-101 Pre-Biologics License Application

July 31st 2023

Influencing and Improving Photoprotection Behaviors in Patients With Xeroderma Pigmentosum

July 12th 2023

Pediatric Necrobiosis Lipoidica Yields Treatment Failure Rate of 40%

July 11th 2023

Alan Mendelsohn, MD, Reviews Phase 3 TMB-001 PK Data for Congenital Ichthyosis

July 5th 2023

Chromhidrosis: A Rare Clinical Finding

June 27th 2023

LEO Pharma to Acquire Timber Pharmaceuticals

August 21st 2023

Abeona Files Briefing Package For EB-101 Pre-Biologics License Application

July 31st 2023

Influencing and Improving Photoprotection Behaviors in Patients With Xeroderma Pigmentosum

July 12th 2023

Pediatric Necrobiosis Lipoidica Yields Treatment Failure Rate of 40%

July 11th 2023

Alan Mendelsohn, MD, Reviews Phase 3 TMB-001 PK Data for Congenital Ichthyosis

July 5th 2023

Chromhidrosis: A Rare Clinical Finding

June 27th 2023

LEO Pharma to Acquire Timber Pharmaceuticals

August 21st 2023

Abeona Files Briefing Package For EB-101 Pre-Biologics License Application

July 31st 2023

Influencing and Improving Photoprotection Behaviors in Patients With Xeroderma Pigmentosum

July 12th 2023

Pediatric Necrobiosis Lipoidica Yields Treatment Failure Rate of 40%

July 11th 2023

Alan Mendelsohn, MD, Reviews Phase 3 TMB-001 PK Data for Congenital Ichthyosis

July 5th 2023

Chromhidrosis: A Rare Clinical Finding

June 27th 2023
© 2023 MJH Life Sciences

All rights reserved.